Published in Blood Weekly, January 13th, 2005
According to a study from the United States, "Abundant biochemical evidence links deficient activity of mitochondrial a-ketoglutarate dehydrogenase with neuropathologically confirmed Alzheimer's disease (AD). Reduced a-ketoglutarate dehydrogenase activity has also been associated with anti-mortem measures of clinical disability.
"One of the genes encoding this complex, namely, DLD, lies within a chromosome 7 region that is in linkage disequilibrium with AD. We therefore examined the hypothesis that variation in DLD is associated with AD risk."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.